1,8-cineole (eucalyptol) in a therapy of respiratory diseases

Czech version

Authors: Zdeňka Navrátilová
Authors‘ workplace: Katedra botaniky PřF UK, Praha
Published in: Čes. slov. Farm., 2024; 73, 181-186
Category: Medical Plants and Nutraceutics
doi: https://doi.org/10.36290/csf.2024.028

Overview

1,8-cineole (eucalyptol) is a natural terpenic compound isolated from eucalyptus essential oil, it is present also in other plant species, especially from Lamiaceae, Myrtaceae, and Zingiberaceae family. Plants containing 1,8-cineole have long been used to treat common cold and other respiratory diseases, gastrointestinal complaints, fever, infections, asthma, rheumatism, and skin conditions. 1,8-cineole is used in foods, cosmetics, perfumery, and also in pharmaceutical industry. 1,8-cineole exerts an antimicrobial, antiviral, mucolytic, anti-inflammatory and bronchodilatory effect and is suitable for the treatment of respiratory infections and other diseases. Medicinal effects were confirmed not only in vitro and in animal studies, but also in clinical trials. Medicinal products and dietary supplements containing 1,8-cineole are available.

Keywords:

1,8-cineole – eucalyptol – respiratory diseases.

Sources

1. Fojtů H. Současná doporučení v prevenci a léčbě sezonních respiračních onemocnění. Med praxi. 2021;18(5):322-6.

2. Hoch CC, Petry J, Griesbaum L, et al. 1,8-cineole (eucalyptol): A versatile phytochemical with therapeutic applications across multiple diseases. Biomed Pharmacother. 2023 Nov;167:115467.

3. Juergens LJ, Worth H, Juergens UR. New Perspectives for Mucolytic, Anti-inflammatory and Adjunctive Therapy with 1,8-Cineole in COPD and Asthma: Review on the New Therapeutic Approach. Adv Ther. 2020 May;37(5):1737-1753.

4. Lewis RA, Larrañaga MD, Lewis RA Sr. Hawley’s Condensed Chemical Dictionary 16^th Ed. Wiley 2016; 1568 p.

5. O’Neil MA, Heckelman PE, Dobbelaar PH, Roman KJ (eds.). The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals, 15^th ed. Royal Society of Chemistry 2013; 2708 p.

6. Cai ZM, Peng JQ, Chen Y, et al. 1,8-Cineole: a review of source, biological activities, and application. J Asian Nat Prod Res. 2021 Oct;23(10):938-54.

7. Tisserand R, Young R. Essential Oil Safety: A Guide for Health Care Professionals 2^nd ed. Churchill Livingstone 2013; 800 p.

8. Martin J, Dušek J. Variabilita a využití silic z Eucalyptus spp. Prakt lékáren. 2007;3(5):238-239.

9. Mączka W, Duda-Madej A, Górny A, et al. Can Eucalyptol Replace Antibiotics? Molecules. 2021 Aug 14;26(16):4933.

10. Kolektiv autorů. Český lékopis 2023. Grada, Praha 2023;4464 p.

11. van Wyk B-E, Wink M. Medicinal Plants of the World. Timber Press, Portland, Oregon, USA 2005;480 p.

12. Merghni A, Belmamoun AR, Urcan AC, et al. 1,8-Cineol (Eucalyptol) Disrupts Membrane Integrity and Induces Oxidative Stress in Methicillin-Resistant Staphylococcus aureus. Antioxidants (Basel). 2023 Jul 6;12(7):1388.

13. Moo CL, Osman MA, Yang SK, et al. Antimicrobial activity and mode of action of 1,8-cineol against carbapenemase-producing Klebsiella pneumoniae. Sci Rep. 2021 Oct 21;11(1):20824.

14. Akhmouch AA, Hriouech S, Mzabi A, et al. Synergistic Action of AMX Associated with 1,8-Cineole and Its Effect on the ESBL Enzymatic Resistance Mechanism. Antibiotics (Basel). 2022 Jul 26;11(8):1002.

15. Kehrl W, Sonnemann U, Dethlefsen U. Therapy for acute nonpurulent rhinosinusitis with cineole: results of a double-blind, randomized, placebo-controlled trial. Laryngoscope. 2004 Apr;114(4):738-42.

16. Fischer J, Dethlefsen U. Efficacy of cineole in patients suffering from acute bronchitis: a placebo-controlled double-blind trial. Cough. 2013;9:25.

17. Kardos P, Khaletskaya O, Kropova O. Efficacy and safety of Cineole (Soledum®) in the treatment of patients with acute bronchitis: results of an open-label randomized clinical phase III study. Clin Phytosci. 2021;7:83.

18. Michalsen A, Goldenstein K, Kardos P, et al. The impact of cineole treatment timing on common cold duration and symptoms: Non-randomized exploratory clinical trial. PLoS One. 2024 Jan 18;19(1):e0296482.

19. Juergens UR, Dethlefsen U, Steinkamp G, et al. Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial. Respir Med. 2003 Mar;97(3):250-6.

20. Juergens UR, Stöber M, Schmidt-Schilling L, et al. Antiinflammatory effects of eucalyptol (1.8-cineole) in bronchial asthma: inhibition of arachidonic acid metabolism in human blood monocytes ex vivo. Eur J Med Res. 1998 Sep 17;3(9):407-12.

21. Worth H, Dethlefsen U. Patients with Asthma Benefit from Concomitant Therapy with Cineole: A Placebo-Controlled, Double-Blind Trial. J Asthma. 2012 Oct;49(8):849-53.

22. Worth H, Schacher C, Dethlefsen U. Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: a placebo-controlled double-blind trial. Respir Res. 2009 Jul 22;10(1):69.

23. Xu J, Hu ZQ, Wang C, et al. Acute and subacute toxicity study of 1,8-cineole in mice. Int J Clin Exp Pathol. 2014 Mar 15;7(4):1495-501.

24. Caldas GF, Limeira MM, Araújo AV, et al. Repeated-doses and reproductive toxicity studies of the monoterpene 1,8-cineole (eucalyptol) in Wistar rats. Food Chem Toxicol. 2016 Nov;97:297-306.

25. Slíva J. Cineol a jeho uplatnění v léčbě respiračních onemocnění. Remedia. 2023;33:62-64.

26. EC (European Commission), Scientific Committee on Food. Opinion of the Scientific Committee on Food on eucalyptol. SCF/CS/FLAV/FLAVOUR/20 ADD2 Final 2002. Available from: https://food.ec.europa.eu/system/files/2016-10/fs_food-improvement-agents_flavourings-out126.pdf [cited 2024 Mar 14].